CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 53 filers reported holding CATALYST BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $41,000 | -68.0% | 62,368 | -55.5% | 0.00% | – |
| Q4 2021 | $128,000 | -69.7% | 140,186 | +126.2% | 0.00% | – |
| Q4 2019 | $422,000 | +152.7% | 61,970 | +173.0% | 0.00% | – |
| Q2 2019 | $167,000 | -26.4% | 22,700 | -18.9% | 0.00% | – |
| Q1 2019 | $227,000 | +14.6% | 28,000 | +11.6% | 0.00% | – |
| Q4 2018 | $198,000 | +17.9% | 25,100 | +60.9% | 0.00% | – |
| Q3 2018 | $168,000 | – | 15,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |